Watermark
  Back to Search Results

BGB-3111-214

Completed

Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-214

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03846427

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2018-001284-24

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20180823

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan Plain Language Summary

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan Plain Language Summary